First report of the hyper-IgM syndrome registry of the latin american society for immunodeficiencies: Novel mutations, unique infections, and outcomes

Journal of Clinical Immunology

Volumn 34, Issue 2, 2014, Pages 146-156

  Cabral Marques, Otavio ^a   Klaver, Stefanie ^a   Schimke, Lena F ^a   Ascendino, Évelyn H ^a   Khan, Taj Ali ^a   Pereira, Paulo Vítor Soeiro ^a   Falcai, Angela ^a   Vargas Hernández, Alexander ^b   Santos Argumedo, Leopoldo ^b   Bezrodnik, Liliana ^c   Moreira, Ileana ^c   Seminario, Gisela ^c   Di Giovanni, Daniela ^c   Raccio, Andrea Gómez ^c   Porras, Oscar ^d   Weber, Cristina Worm ^e   Ferreira, Janaíra Fernandes ^f   Tavares, Fabiola Scancetti ^g   De Carvalho, Elisa ^g   Valente, Claudia França Cavalcante ^g   Kuntze, Gisele ^h   Galicchio, Miguel ⁱ   King, Alejandra ^j   Rosário Filho, Nelson Augusto ^k   Grota, Milena Baptistella ^l   Dos Santos Vilela, Maria Marluce ^l   Di Gesu, Regina Sumiko Watanabe ^m   Lima, Simone ⁿ   De Souza Moura, Leiva ⁿ   Talesnik, Eduardo ^o   Mansour, Eli ^l   Roxo Junior, Pérsio ^a   Aldave, Juan Carlos ^p   Goudouris, Ekaterine ^q   Pinto Mariz, Fernanda ^q   Berrón Ruiz, Laura ^r   Staines Boone, Tamara ^s   Calderón, Wilmer O Córdova ^t   Del Carmen Zarate Hernández, María ^u   Grumach, Anete S ^v   Sorensen, Ricardo ^w   Durandy, Anne ^x   Torgerson, Troy R ^y   Carvalho, Beatriz Tavares Costa ^z   Espinosa Rosales, Francisco ^r   Ochs, Hans D ^y   Condino Neto, Antonio ^a   more..

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

^c HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

^d HOSPITAL NACIONAL DE NIÑOS   (Costa Rica)

^e Pediatric Allergy and Immunology Clinic   (Brazil)

^f Albert Sabin Hospital   (Brazil)

^g HOSPITAL DE BASE DO DISTRITO FEDERAL   (Brazil)

^h Integrated Center of Pediatric Specialties   (Brazil)

ⁱ Jefe de la Unidad de Quemados y Servicio de Cirugía Plástica y Reconstructiva del Hospital de Niños V J Vilela   (Argentina)

^j HOSPITAL LUIS CALVO MACKENNA   (Chile)

^k FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^l UNIVERSITY OF CAMPINAS   (Brazil)

^m Hospital Conceicao   (Brazil)

ⁿ Childrens Hospital Lucídio Portela   (Brazil)

^o PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^p HOSPITAL NACIONAL EDGARDO REBAGLIATI MARTINS   (Peru)

^q FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^r INSTITUTO NACIONAL DE PEDIATRÍA   (Mexico)

^s INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^t Unidad de Inmunología   (Peru)

^u HOSPITAL UNIVERSITARIO DR JOSÉ ELEUTERIO GONZÁLEZ   (Mexico)

^v FACULDADE DE MEDICINA DO ABC   (Brazil)

^w CHILDREN S HOSPITAL   (United States)

^x HÔPITAL NECKER ENFANTS MALADES   (France)

^y UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^z FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

more..

Author keywords

AID deficiency, infections, mutations; CD40L deficiency; Hyper IgM syndrome; Latin American Society for Immunodeficiencies

Indexed keywords

ACTIVATION INDUCED CYTIDINE DEAMINASE; CD40 LIGAND; CYTIDINE DEAMINASE; GANCICLOVIR; METHYLPREDNISOLONE; RITUXIMAB;

ADOLESCENT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIBIOTIC PROPHYLAXIS; ARTICLE; ASPERGILLOSIS; ASPERGILLUS; AUTOIMMUNE HEMOLYTIC ANEMIA; AUTOIMMUNITY; BONE MARROW TRANSPLANTATION; CHILD; CLINICAL FEATURE; CLINICAL STUDY; CYTOMEGALOVIRUS INFECTION; DIARRHEA; ENZYME DEFICIENCY; FEMALE; GENE MUTATION; GENETIC DISORDER; GENOTYPE; GRAFT VERSUS HOST REACTION; HUMAN; HYPER IGM SYNDROME; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; INFANT; ISOSPORA BELLI; MAJOR CLINICAL STUDY; MALE; MICROSPORIDIA; MICROSPORIDIOSIS; MISSENSE MUTATION; MOLECULAR DIAGNOSIS; MYCOPLASMA PNEUMONIAE; OPPORTUNISTIC INFECTION; PHENOTYPE; PNEUMONIA; PRIORITY JOURNAL; REGISTER; RESPIRATORY TRACT INFECTION; RETROSPECTIVE STUDY; SEPSIS; SERRATIA MARCESCENS; SOUTH AND CENTRAL AMERICA;

CD40 LIGAND; CHILD, PRESCHOOL; COMORBIDITY; CYTIDINE DEAMINASE; FEMALE; HISPANIC AMERICANS; HUMANS; HYPER-IGM IMMUNODEFICIENCY SYNDROME; INFANT; INFANT, NEWBORN; INFECTION; LUNG; MALE; REGISTRIES; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84898869336     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-013-9980-4     Document Type: Article

References (51)

1. Notarangelo LD, Duse M, Ugazio AG. Immunodeficiency with hyper-IgM (HIM). Immunodefic Rev. 1992;3(2):101-21.
2. Burtin P. An example of atypical agammaglobulinemia (a case of severe hypogammaglobulinemia with increase of the beta-2 macroglobulin. Rev Fr Etud Clin Biol. 1961;6:286-9.
3. Israel-Asselain R, Burtin P, Chebat J. A new biological disorder: agammaglobulinemia with beta2-macroglobulinemia (a case). Bull Mem Soc Med Hop Paris. 1960;76:519-23.
4. Rosen FS, Kevy SV, Merler E, Janeway CA, Gitlin D. Dysgammaglobulinaemia and recurrent bacterial infection. Lancet. 1961;1(7179):700.
5. Allen RC, Armitage RJ, Conley ME, Rosenblatt H, Jenkins NA, Copeland NG, et al. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science. 1993;259(5097):990-3.
6. Aruffo A, Farrington M, Hollenbaugh D, Li X, Milatovich A, Nonoyama S, et al. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell. 1993;72(2):291-300.
7. DiSanto JP, Bonnefoy JY, Gauchat JF, Fischer A, de Saint BG. CD40 ligand mutations in x-linked immunodeficiency with hyper-IgM. Nature. 1993;361(6412):541-3.
8. Fuleihan R, Ramesh N, Loh R, Jabara H, Rosen RS, Chatila T, et al. Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM. Proc Natl Acad Sci U S A. 1993;90(6):2170-3.
9. Korthauer U, Graf D, Mages HW, Briere F, Padayachee M, Malcolm S, et al. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature. 1993;361(6412):539-41.
10. Doffinger R, Smahi A, Bessia C, Geissmann F, Feinberg J, Durandy A, et al. X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling. Nat Genet. 2001;27(3):277-85.
11. Jain A, Ma CA, Liu S, Brown M, Cohen J, Strober W. Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia. Nat Immunol. 2001;2(3):223-8.
12. Revy P, Muto T, Levy Y, Geissmann F, Plebani A, Sanal O, et al. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell. 2000;102(5):565-75.
13. Imai K, Slupphaug G, Lee WI, Revy P, Nonoyama S, Catalan N, et al. Human uracil-DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination. Nat Immunol. 2003;4(10):1023-8.
14. Peron S, Metin A, Gardes P, Alyanakian MA, Sheridan E, Kratz CP, et al. Human PMS2 deficiency is associated with impaired immunoglobulin class switch recombination. J Exp Med. 2008;205(11):2465-72.
15. Lee WI, Torgerson TR, Schumacher MJ, Yel L, Zhu Q, Ochs HD. Molecular analysis of a large cohort of patients with the hyper immunoglobulin M (IgM) syndrome. Blood. 2005;105(5):1881-90.
16. Notarangelo LD, Lanzi G, Peron S, Durandy A. Defects of class-switch recombination. J Allergy Clin Immunol. 2006;117(4):855-64.
17. Cabral-Marques O, Arslanian C, Ramos RN, Morato M, Schimke L, Soeiro Pereira PV, et al. Dendritic cells from X-linked hyper-IgM patients present impaired responses to Candida albicans and Paracoccidioides brasiliensis. J Allergy Clin Immunol. 2012;129(3):778-86.
18. Jain A, Atkinson TP, Lipsky PE, Slater JE, Nelson DL, Strober W. Defects of T-cell effector function and post-thymic maturation in X-linked hyper-IgM syndrome. J Clin Invest. 1999;103(8):1151-8.
19. Winkelstein JA, Marino MC, Ochs H, Fuleihan R, Scholl PR, Geha R, et al. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients. Medicine (Baltimore). 2003;82(6):373-84.
20. Cabral-Marques O, Schimke LF, Pereira PV, Falcai A, de Oliveira JB, Hackett MJ, et al. Expanding the clinical and genetic spectrum of human CD40L deficiency: the occurrence of paracoccidioidomycosis and other unusual infections in Brazilian patients. J Clin Immunol. 2012;32(2):212-20.
21. Quartier P, Bustamante J, Sanal O, Plebani A, Debre M, Deville A, et al. Clinical, immunologic and genetic analysis of 29 patients with autosomal recessive hyper-IgM syndrome due to Activation-Induced Cytidine Deaminase deficiency. Clin Immunol. 2004;110(1):22-9.
22. Seyama K, Nonoyama S, Gangsaas I, Hollenbaugh D, Pabst HF, Aruffo A, et al. Mutations of the CD40 ligand gene and its effect on CD40 ligand expression in patients with X-linked hyper IgM syndrome. Blood. 1998;92(7):2421-34.
23. den Dunnen JT, Antonarakis SE. Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat. 2000;15(1):7-12.
24. Taschner PE, den Dunnen JT. Describing structural changes by extending HGVS sequence variation nomenclature. Hum Mutat. 2011;32(5):507-11.
25. Danielian S, Oleastro M, Eva Rivas M, Cantisano C, Zelazko M. Clinical follow-up of 11 Argentinian CD40L-deficient patients with 7 unique mutations including the so-called "milder" mutants. J Clin Immunol. 2007;27(4):455-9.
26. Vargas-Hernandez A, Berron-Ruiz L, Staines-Boone T, Zarate-Hernandez M, Cordova-Calderon W, Espinosa-Rosales F, et al. Clinical and genetic analysis of patients with X-linked hyper-IgM syndrome. Clin Genet. 2012 Sep 10.
27. Lin Q, Rohrer J, Allen RC, Larche M, Greene JM, Shigeoka AO, et al. A single strand conformation polymorphism study of CD40 ligand. Efficient mutation analysis and carrier detection for X-linked hyper IgM syndrome. J Clin Invest. 1996;97(1):196-201.
28. Macchi P, Villa A, Strina D, Sacco MG, Morali F, Brugnoni D, et al. Characterization of nine novel mutations in the CD40 ligand gene in patients with X-linked hyper IgM syndrome of various ancestry. Am J Hum Genet. 1995;56(4):898-906.
29. Prasad ML, Velickovic M, Weston SA, Benson EM. Mutational screening of the CD40 ligand (CD40L) gene in patients with X linked hyper-IgM syndrome (XHIM) and determination of carrier status in female relatives. J Clin Pathol. 2005;58(1):90-2.
30. Mu Y, Prochnow C, Pham P, Chen XS, Goodman MF. A structural basis for the biochemical behavior of activation-induced deoxycytidine deaminase class-switch recombination-defective hyper-IgM-2 mutants. J Biol Chem. 2012;287(33):28007- 16.
31. Levy J, Espanol-Boren T, Thomas C, Fischer A, Tovo P, Bordigoni P, et al. Clinical spectrum of X-linked hyper-IgM syndrome. J Pediatr. 1997;131(1 Pt 1):47-54.
32. Minegishi Y, Lavoie A, Cunningham-Rundles C, Bedard PM, Hebert J, Cote L, et al. Mutations in activation-induced cytidine deaminase in patients with hyper IgM syndrome. Clin Immunol. 2000;97(3):203-10.
33. Ferrari S, Giliani S, Insalaco A, Al-Ghonaium A, Soresina AR, Loubser M, et al. Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM. Proc Natl Acad Sci U S A. 2001;98(22):12614-9.
34. Condino-Neto A, Franco JL, Espinosa-Rosales FJ, Leiva LE, King A, Porras O, et al. Advancing the management of primary immunodeficiency diseases in Latin America: Latin American Society for Immunodeficiencies (LASID) Initiatives. Allergol Immunopathol (Madr). 2012;40(3):187-93.
35. Condino-Neto A, Franco JL, Trujillo-Vargas C, Espinosa-Rosales FJ, Leiva LE, Rodriguez-Quiroz F, et al. Critical issues and needs in management of primary immunodeficiency diseases in Latin America. Allergol Immunopathol (Madr). 2011;39(1):45-51.
36. Durandy A, Revy P, Fischer A. Human models of inherited immunoglobulin class switch recombination and somatic hypermutation defects (hyper-IgM syndromes). Adv Immunol. 2004;82:295-330.
37. Erdos M, Lakos G, Derfalvi B, Notarangelo LD, Durandy A, Marodi L. Molecular genetic analysis of Hungarian patients with the hyper-immunoglobulin M syndrome. Mol Immunol. 2008;45(1):278-82.
38. Krones E, Hogenauer C. Diarrhea in the immunocompromised patient. Gastroenterol Clin North Am. 2012;41(3):677-701.
39. Ben-Ari J, Wolach O, Gavrieli R, Wolach B. Infections associated with chronic granulomatous disease: linking genetics to phenotypic expression. Expert Rev Anti Infect Ther. 2012;10(8):881-94.
40. Foy HM, Ochs H, Davis SD, Kenny GE, Luce RR. Mycoplasma pneumoniae infections in patients with immunodeficiency syndromes: report of four cases. J Infect Dis. 1973;127(4):388-93.
41. Gelfand EW. Unique susceptibility of patients with antibody deficiency to mycoplasma infection. Clin Infect Dis. 1993;17 Suppl 1:S250-3.
42. Henriet SS, Verweij PE, Warris A. Aspergillus nidulans and chronic granulomatous disease: a unique host-pathogen interaction. J Infect Dis. 2012;206(7):1128-37.
43. Marcinkowski M, Bauer K, Stoltenburg-Didinger G, Vogel M, Versmold H. Fatal aspergillosis with brain abscesses in a neonate with DiGeorge syndrome. Pediatr Infect Dis J. 2000;19(12):1214-6.
44. Silva GB, Fernandes KP, Segundo GR. Common variable immunodeficiency and isosporiasis: first report case. Rev Soc Bras Med Trop. 45(6):768-9.
45. Wolach B, Eliakim A, Gottesman G, Yellin A. Pulmonary aspergillosis in a child with hyperimmunoglobulin E syndrome. Clin Infect Dis. 1998;26(1):204-5.
46. Yoshihara T, Morimoto A, Nakauchi S, Fujii N, Tsunamoto K, Misawa A, et al. Successful transplantation of haploidentical CD34+ selected bone marrow cells for an infantile case of severe combined immunodeficiency with aspergillus pneumonia. Pediatr Hematol Oncol. 2002;19(6):439-43.
47. Subauste CS, Wessendarp M, Sorensen RU, Leiva LE. CD40-CD40 ligand interaction is central to cell-mediated immunity against Toxoplasma gondii: patients with hyper IgM syndrome have a defective type 1 immune response that can be restored by soluble CD40 ligand trimer. J Immunol. 1999;162(11):6690-700.
48. Fontana S, Moratto D, Mangal S, De Francesco M, Vermi W, Ferrari S, et al. Functional defects of dendritic cells in patients with CD40 deficiency. Blood. 2003;102(12):4099-106.
49. Seyama K, Kobayashi R, Hasle H, Apter AJ, Rutledge JC, Rosen D, et al. Parvovirus B19-induced anemia as the presenting manifestation of X-linked hyper-IgM syndrome. J Infect Dis. 1998;178(2):318-24.
50. Gratwohl A, Baldomero H, Aljurf M, Pasquini MC, Bouzas LF, Yoshimi A, et al. Hematopoietic stem cell transplantation: a global perspective. JAMA. 2010;303(16):1617-24.
51. Guerra-Maranhao MC, Costa-Carvalho BT, Nudelman V, Barros-Nunes P, Carneiro-Sampaio MM, Arslanian C, et al. Response to polysaccharide antigens in patients with ataxia-telangiectasia. J Pediatr (Rio J). 2006;82(2):132-6.